X
X
X

Filters close
Released: 23-May-2022 10:05 AM EDT
Experts stress importance of monitoring for post-treatment opioid use in young sarcoma patients
Wiley

New analysis finds more than half of U.S. adolescents and young adults with sarcoma—a type of cancer in the bones or soft tissues—are often prescribed opioids to treat their pain.

Newswise: National Comprehensive Cancer Network Honors Oncology Leaders Promoting Progress in Cancer Care
Released: 23-May-2022 8:30 AM EDT
National Comprehensive Cancer Network Honors Oncology Leaders Promoting Progress in Cancer Care
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network honors oncology leaders: Robert Winn, MD, and Shonta Chambers, MSW, named joint Partners in Cancer Care; William Gradishar, MD, named Rodger Winn Award recipient for work on NCCN Guidelines; Hema Sundar, PhD, named Employee of the Year.

access_time Embargo lifts in 2 days
Embargo will expire: 24-May-2022 3:00 AM EDT Released to reporters: 22-May-2022 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-May-2022 3:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Cedars-Sinai’s Dean, Shlomo Melmed, MB, ChB, Honored for Contributions to Endocrine Research
Released: 20-May-2022 4:15 PM EDT
Cedars-Sinai’s Dean, Shlomo Melmed, MB, ChB, Honored for Contributions to Endocrine Research
Cedars-Sinai

Shlomo Melmed, MB, ChB, a world-renowned leader in pituitary medicine, was named the inaugural recipient of the Transatlantic Alliance Award by the European Society of Endocrinology (ESE) and the Endocrine Society for his pioneering research in pituitary medicine and endocrine tumors.

Released: 20-May-2022 3:25 PM EDT
Medicinal cannabis shown to reduce pain and need for opiate painkillers among cancer patients
Frontiers

A comprehensive assessment of the benefits of medical cannabis for cancer-related pain found that for most oncology patients, pain measures improved significantly, other cancer-related symptoms also decreased, the consumption of painkillers was reduced, and the side effects were minimal.

Newswise: Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer
Released: 20-May-2022 9:45 AM EDT
Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer
Yale Cancer Center

Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.

Released: 20-May-2022 7:00 AM EDT
Grant from Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer
Research to Prevent Blindness

Research to Prevent Blindness and Castle Biosciences today announced that they are partnering to increase opportunities for medical students to gain research experiences, specifically in the field of ocular cancer.

Newswise: Cedars-Sinai Cancer: Erasing LGBTQ+ Healthcare Disparities
Released: 19-May-2022 3:00 PM EDT
Cedars-Sinai Cancer: Erasing LGBTQ+ Healthcare Disparities
Cedars-Sinai

Studies have shown that the way LGBTQ+ patients are screened, diagnosed and treated for cancer may put them at a significant disadvantage compared to cisgender heterosexual patients.

Released: 19-May-2022 2:50 PM EDT
Study tests link between common blood pressure pills and breast cancer
Curtin University

Curtin University researchers will examine if the long-term use of a popular blood pressure medication increased the risk of breast cancer in almost 200,000 women as part of a new project supported by the Federal Government.

Released: 19-May-2022 2:40 PM EDT
Standard test for multiple myeloma provides clues of a rare, more deadly type
Medical College of Georgia at Augusta University

A test for the common blood cancer multiple myeloma also holds clear clues that the patient has one of the most uncommon and deadly forms of this cancer, investigators say.

Newswise: Retired Science Teacher Relies on Former Student When Faced With Bladder Cancer
Released: 19-May-2022 12:55 PM EDT
Retired Science Teacher Relies on Former Student When Faced With Bladder Cancer
Hackensack Meridian Health

Intravesical chemotherapy, is specifically for patients with recurrent non-muscle bladder cancers that aren’t responding to BCG. Up to 50 percent of patients respond to this therapy, helping them avoid major surgery.

Released: 19-May-2022 11:55 AM EDT
Montefiore Einstein Cancer Center Researchers Receive Price Family Foundation Health Equity Research Awards
Albert Einstein College of Medicine

The National Cancer Institute-designated Montefiore Einstein Cancer Center (MECC) has partnered with the Price Family Foundation to fund eight research teams developing novel cancer therapies and improving cancer outcomes for historically marginalized communities in the Bronx.

Newswise: Exploring Cancer and Health Data on Asian American and Pacific Islanders
Released: 19-May-2022 10:05 AM EDT
Exploring Cancer and Health Data on Asian American and Pacific Islanders
Rutgers Cancer Institute of New Jersey

Cancer health disparities are often identified from population-based surveillance data routinely captured by statewide cancer registries. Antoinette Stroup, PhD, of Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute – Designated Comprehensive Cancer Center together with RWJBarnabas Health and Rutgers School of Public Health is the director of the New Jersey State Cancer Registry (NJSCR), explores cancer and health data on the Asian American and Pacific Islander population.

Newswise: Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Released: 19-May-2022 10:05 AM EDT
Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients
Rutgers Cancer Institute of New Jersey

Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.

access_time Embargo lifts in 2 days
Embargo will expire: 23-May-2022 11:00 AM EDT Released to reporters: 18-May-2022 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-May-2022 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Armando E. Giuliano, MD, Expands Role
Released: 18-May-2022 2:05 PM EDT
Armando E. Giuliano, MD, Expands Role
Cedars-Sinai

Pioneering breast cancer surgeon, clinician and researcher Armando E. Giuliano, MD-who helped introduce sentinel lymph node biopsy in the early 1990s, sparing many women the need for major breast cancer surgery-has been named regional medical director of the Cedars-Sinai Cancer Breast Oncology Program.

Released: 18-May-2022 1:10 PM EDT
'Honey, Don't Forget the Sunscreen!' Three Beliefs That Affect Sunscreen Use by Older Adults
Wolters Kluwer Health: Lippincott

Reminders from a romantic partner might be an effective way to encourage sunscreen use by people age 50 or older, suggests a study in the May/June issue of The Journal of the Dermatology Nurses' Association, official publication of the Dermatology Nurses' Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 18-May-2022 12:05 PM EDT
New Surgical Robot Is Safe and Effective for Localized Prostate Cancer Surgery
Wolters Kluwer Health: Lippincott

A new surgical robotic system is "feasible, safe, and effective" for treatment of early-stage prostate cancer, concludes an initial evaluation in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.


Showing results

120 of 20918

close
32.06132